Sure U, Berghorn W J, Bertalanffy H, Wakabayashi T, Yoshida J, Sugita K, Seeger W
Neurochirurgische Universitätsklinik Freiburg, Federal Republic of Germany.
Acta Neurochir (Wien). 1995;132(1-3):59-65. doi: 10.1007/BF01404849.
Although recently survival of some medulloblastoma patients increased remarkably, it remains a serious diagnosis in others. In order to predict the postoperative prognosis in patients treated for medulloblastoma, a new staging, scoring and grading system was developed. Sixty-six patients operated on microsurgically between 1975 and 1990 at a single neurosurgical center were fully followed-up. No patient was excluded due to a poor postoperative course. Completion of commonly used radiotherapy protocols was attempted in all patients. Survival of patients was evaluated by the Kaplan-Meier method. The following 5 parameters were selected to define subgroups: patients' age, tumour location and histology, degree of resection and presence or absence of metastases. Patients older than 10 years had a better prognosis than individuals aged 10 or less (p < 0.01), patients with lateral tumours had a better prognosis than patients with midline tumours with brain stem infiltration (p < 0.05), patients with complete tumour resection had a more favourable prognosis than individuals with subtotal (p < 0.01) or partial resection (p < 0.001), patients without metastases at the time of diagnosis had a better prognosis than individuals without such evidence (p < 0.001), patients with the desmoplastic tumour variant had a better prognosis than patients with classical tumour histology (p < 0.01). According to the prognosis of a distinct subgroup, scoring points were distributed which correlated with the degree of inter-subgroup significances. The sum of a single patient's scoring points was called the total score. Based on this score, three groups of prognosis were distinguished.(ABSTRACT TRUNCATED AT 250 WORDS)
尽管最近一些髓母细胞瘤患者的生存率显著提高,但对其他患者来说,这仍然是一个严重的诊断。为了预测接受髓母细胞瘤治疗患者的术后预后,开发了一种新的分期、评分和分级系统。对1975年至1990年在单一神经外科中心接受显微手术的66例患者进行了全面随访。没有患者因术后病程不佳而被排除。所有患者都尝试完成常用的放疗方案。采用Kaplan-Meier法评估患者的生存率。选择以下5个参数来定义亚组:患者年龄、肿瘤位置和组织学、切除程度以及有无转移。10岁以上的患者比10岁及以下的个体预后更好(p<0.01),侧方肿瘤患者比有脑干浸润的中线肿瘤患者预后更好(p<0.05),肿瘤完全切除的患者比次全切除(p<0.01)或部分切除(p<0.001)者预后更有利,诊断时无转移的患者比无此类证据的个体预后更好(p<0.001),促纤维增生型肿瘤变体患者比经典肿瘤组织学患者预后更好(p<0.01)。根据不同亚组的预后,分配与亚组间显著性程度相关的评分点。单个患者的评分点总和称为总分。基于该评分,区分出三组预后。(摘要截断于250字)